The latest from BioStock
» Carbiotix evaluates new fiber raw materials
» Emplicure's CEO on the strength of the business model
» BioStock Analysis: RhoVac
» Lipum on CRO collaboration ahead of Phase I
» The Ukraine crisis – an ethical dilemma for the life science sector
Read BioStock's newsletter for v.12 here.
BrainCool receives notification of an additional 4 MSEK in payments from an ongoing EU grant. Read more.
appoints new distributor for Efemia Bladder Support in Great Britain and Ireland. Read more.
Nightingale Health launches Live by Nightingale through its home testing solution. Read more.
RealHeart begins testing of clinical version of RealHeart TAH on virtual patients. Read more.
Eurocine Vaccines announces outcome of option redemption, approximately SEK 4,5 million is added. Read more.
Novozymes announces plans to raise prices to cover rising costs of raw materials, energy and logistics. Read more.
RISE new subsidiaries will certify medical technology solutions according to MDR. Read more.
The number life science company in the Stockholm-Uppsala area has increased by almost 50% in ten years. Read more.
Modulight receives an order from a large pharmaceutical company for a pilot project. Read more.
Great interest in ProstaLunds CoreTherm-experience meeting. Read more.
HC Andersen Capital has published a new investment case: Ascelia Pharma. Read more.
Brighter subsidiary Nectarine Health signs an agreement regarding user testing with JRW Services in the USA. Read more.
Duearity has submitted the company's technical file – the final phase of the CE marking process. Read more. Proposal for two new board members in the company has been submitted. Read more.
Annual reports:
BioArctic ContextVision Enzymatica Getinge Idogen Infant Bacterial Therapeutics Orexo Ortivus Stille XP Chemistries
Notices of general meetings:
AddLife ContextVision Elos Medtech Humana Odinwell Redsense Respirator SenzaGen
Communiqués:
Active Biotech Alligator Bioscience Ascelia Pharma Cessatech Nexstim Oncopeptides Vivesto
News received since Wednesday lunch:
Yesterday, Wednesday, the subscription period began for Phase Holographic Imaging's Rights issue of units. Read more.
The nomination committee's proposal regarding elections and remuneration for the annual general meeting in Respirator. Read more.
Herantis Pharma has successfully completed a new share issue of EUR 1,46 million. Read more.
Third municipality starts up with Medimis MedimiSmart in Norway. Read more.
Medistim has announced dividend proposals for 2021. Read more.
Interview with Abera Biosciences vd Maria Alriksson about the company's background and research progress. Read more.
Zealand Pharma has appointed a new CEO, refocusing strategy to prioritize R&D and streamline operations. Read more.
This morning's winner: DexTech Medical 20,0%, Aptahem 8,2%, Scandinavian Chemotech 8,0%, Ortivus 8,0%, Prostatype Genomics 7,0%
Morning loser: PharmaLundensis -13,0%, Selectimmune Pharma -10,7%, Inhalation Sciences -9,5%, Lipum -8,1%, Carbiotix -7,0%
Index: OMXS30 2111 -0,90%, Healthcare -0,12%
More articles from BioStock
» DexTech's stock pressured despite expanded pipeline
» BioStock Studio: Pharmiva's Chairman of the Board on the expansion plans
» Principal investigator on Idogen's clinical study with IDO 8
» Carbiotix prebiotic fiber in clinical trial against type 2 diabetes
» BioStock Studio: Alligator Bioscience's CEO on the latest data